| Literature DB >> 29067019 |
Louise K Jensen1, Anne S B Johansen1, Henrik E Jensen1.
Abstract
Bacterial biofilm formation is one of the main reasons for a negative treatment outcome and a high recurrence rate for many chronic infections in humans. The optimal way to study both the biofilm forming bacteria and the host response simultaneously is by using discriminative, reliable, and reproducible animal models of the infections. In this review, the advantages of in vivo studies are compared to in vitro studies of biofilm formation in infectious diseases. The pig is the animal of choice when developing and applying large animal models of infectious diseases due to its similarity of anatomy, physiology, and immune system to humans. Furthermore, conventional pigs spontaneously develop many of the same chronic bacterial infections as seen in humans. Therefore, in this review porcine models of five different infectious diseases all associated with biofilm formation and chronicity in humans are described. The infectious diseases are: chronic wounds, endocarditis, pyelonephritis, hematogenous osteomyelitis, and implant-associated osteomyelitis (IAO).Entities:
Keywords: animal model; biofilm; chronic wounds; endocarditis; hematogenous osteomyelitis; implant-associated osteomyelitis; pig; pyelonephritis
Year: 2017 PMID: 29067019 PMCID: PMC5641329 DOI: 10.3389/fmicb.2017.01961
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 5.640
Figure 1(A) Chronic venous leg ulcer. (B) Biofilm of P. aeruginosa [red stain] and S. aureus [green stain], identified by specific PNA FISH probes, surrounded by host cells (DAPI [blue stain]) in a human chronic wound. (C) CSLM three dimensional imaging of picture B. (D) Enlargement of picture C. The white arrows point to bacterial aggregates and the yellow arrows point to the wound surface (Kirketerp-Møller et al., 2008).
Pros and cons of studying biofilm in regard to bacterial diseases in Vitro vs. in Vivo.
| Simple | No host influence | |
| Reproducible | Inferior in treatment studies | |
| Cheap | “Mushroom” structure | |
| Non-invasive | ||
| Host influence | Expensive | |
| Ideal in treatment studies | Complex | |
| Natural biofilm formation | Biological variation | |
| Invasive |
Figure 2Establishment of four different models in conventional pigs of 30 kg. (A) Implant associated osteomyelitis, a drill hole is created in the right tibia followed by injection of bacteria and insertion of a small metal implant (Jensen et al., 2017). (B) Intravenous inoculation of bacteria for induction of endocarditis. Four days prior to inoculation, a permanent catheter was placed in the left ventricle (Christiansen et al., 2013b). (C) Free dissection of the right ureter, followed by insertion of a catheter used for inoculation of bacteria directly in the renal pelvis (Isling et al., 2011). (D) Four wounds created on the back at different time intervals for bacterial inoculation.
Figure 3Left column: chronic spontaneous bacterial infections in conventional pigs (A–D) and a human (E). Middle column: experimental porcine models of human infections. Right column (except from picture A3): microscopy of the lesions present in the middle column. Row A: Chronic wounds. A1: Shoulder ulceration. A2: wound located on the back. A3: Bacteria (arrow) in a shoulder ulceration from a conventional pig. Row B: Endocarditis. B1: Left side, thrombotic valvular endocarditis (arrow). B2: A permanent catheter (arrow) inserted into the left ventricle prior to inoculation of bacteria. B3: Immunohistochemical staining of S. aureus (arrow) on the mitral valve (Christiansen et al., 2013b). Row C: Pyelonephritis. C1, C2: Polar located lesions of pyelonephritis (arrows). C3: Immunohistochemical staining of E. coli (arrows) in the proximal tubuli (Isling et al., 2011). Row D: Hematogenous osteomyelitis. D1, D2: Purulent osteomyelitis (O) in the femur. D3: Immunohistochemical staining of S. aureus (arrow) located in the capillary loops of the metaphysis (Johansen et al., 2012b). Row E: Implant-associated osteomyelitis. E1: Infected osteo-syntheses of the ankle. E2: Peri-implant infected bone tissue (double arrow) surrounding the implant cavity (ic), the implant has been removed. E3: Immunohistochemical staining of S. aureus (arrow) and in the insert (Jensen et al., 2017).
Porcine models of chronic wounds.
| Breuing et al., | 3 | 24 | 45 | F | Yorkshire | 48 | 2–47 days | Partial thickness (burn) wounds Wound chamber | 108 | 1.2 ml | Topical | T: CFU + Histology I: NA | Acute | |
| Davis et al., | 6 | NR | 25–35 | F | NR | <279 | 48 h | Partial thickness wounds Wound dressing | 107 | NR | Topical | T: Histology + SEM + EpiM I: NA | Acute | |
| Hirsch et al., | 4 | NR | 50–60 | F | Yorkshire (±diabetic) | 56 | 12 days | Full thickness (diabetic) wounds Wound chamber | 2 × 108 | NR | Topical | T: CFU + Histology I: NA | Chronic | |
| Roche et al., | 40 | NR | 20–25 | F | Yorkshire crossbred | 640–800 | 21 days | Full thickness wounds Wound dressing | 1 × 107 1 × 108 | 0.5 or 2 ml | Topical | T: CFU + Histology + SEM I: NA | Chronic | |
| Nusbaum et al., | 9 | NR | 35–40 | F | NR | 135 | 23 days | Partial thickness Wound dressing | 106 | 25 μl | Topical | T: CFU + Histology I: NA | Chronic | |
| Davis et al., | 6 | NR | 40–55 | F | NR | 36 | 21 days | Full thickness wounds Wound dressing | 500 | NR | Topical | T: PCR + CFU I: NA | Chronic | |
T, verification method in tissue; I, verification method on implant; CFU, colony forming units; SEM, scanning electron microscopy; EpiM, epifluorescence microscopy; NR, not registered; F, female. NA, not available.
Porcine models of endocarditis.
| Jones, | 17 | 8–12 and 12–14 | NR | M/F | Yorkshire | 2–47 days | None | 108 | 10 ml | I.V. | T: Microbiology + Histology I: NRV | Acute | S85: 77% | |
| Geissinger et al., | 64 | 12–20 and 3 or 10 | NR | M/F | Yorkshire Conventional and Gnotobiotic | 2–12 days | None | Two strains of | A: 2 × 109–9 × 1010 B: 8 × 1011
| 7-10 ml | S.C. | T: Histology (LM and SEM) I: NRV | Acute | Strain A: Conventional: 37% Gnotobiotic: 55% |
| Jones, | 60 | 8–12 | NR | M/F | Yorkshire | 10–35 days | None | 108 | 10 ml | I.V. | T: Microbiology I: NRV | Acute | 50% | |
| Jones, | 23 | 8–12 | NR | M/F | Yorkshire | 18–48 h | None | 108 | 10 ml | I.V. | T: Microbiology + Histology I: NRV | Acute | 60% | |
| Johnson et al., | 41 | 3–4 | NR | M/F | Crossbred | 24 days | Catheter | 1 × 107 | NR | I.V. | T: Microbiology + Histology I: NR | Acute | Catheter: 94% No catheter: 11% | |
| Dewar et al., | 10 | NR | 25–35 | M | Göttingen mini-pigs | 20–55 days | Catheter | 3 × 108 | NR | I.V. | T: NR I: NR | NR | 75% | |
| Christiansen et al., | 14 | 6–9 | 13–25 | F | Yorkshire-Landrace crossbred | 1–11 days | Catheter | 105–107 | 13-25 ml | I.V. | T: Microbiology + Histology I: NR | Acute | Both strains: 25% S54F9 107 CFU: 100% | |
| Christiansen et al., | 17 | 6–10 | 13–25 | F | Yorkshire-Landrace crossbred | 1–11 days | Catheter | 105–108 | 13-25 ml | I.V. | T: Microbiology + Histology I: NR | NR | Both strains: 22% S54F9 107 CFU: 100% | |
The percentage of animals with infection. T, verification method in tissue; I, verification method on implant; CFU, colony forming units; NR, not registered; F, female; M, male; I.V, intravenous; S.C., sub cutaneous; NRV, not relevant.
Porcine models of pyelonephritis.
| Hodson et al., | 35 | NR | NR | F | Sinclair mini-pig | 7–130 days | Vesico-urethral reflux | NR | NR | Intravesical | T: Microbiology + Histology I: NRV | Acute + Chronic | 64% | |
| Ransley and Risdon, | 43 | 2-4 | NR | M/F | NR | 1–4 weeks | Vesico-urethral reflux Paraffin wax | NR | 5–10 ml | Intravesical | T: Microbiology + Histology I: NR | Chronic | Control: 33–68% Gentamicin+ Chloramphenicol: 11% Nitrofurantoin: 19% | |
| Farhat et al., | 10 | 3-4 | 10 | F | Yorkshire | 6–8 weeks | Vesico-urethral reflux Paraffin wax | NR | NR | Intravesical | T: Microbiology + Histology + Ultrasound I: NR | Chronic | 67% | |
| Isling et al., | 9 | NR | 19 | F | Yorkshire crossbred | 6 h | Catheter | 109 | 3.25 ml × 3 | In renal pelvis | T: Microbiology + Histology I: NR | Acute | All strains: 88% | |
xThe percentage of animals with infection. T, verification method in tissue; I, verification method on implant; CFU, colony forming units; NR, not registered; F, female; M, male; NRV, not relevant.
Porcine models of hematogenous osteomyelitis.
| Wood et al., | 18 | 10–12 | NR | M/F | Crossbred | 58–63 days | None | Richards: 6.39 × 108 Strain 25: 1.55 × 108 | 3 ml | I.V. | T: Microbiology + Histology I: NRV | Chronic | Both strains: 83% | |
| Jensen et al., | 16 | 8 | 20-25 | F | Yorkshire-Landrace crossbred | 6–48 h | None | 1 × 108 | 1 ml/kg (1–2x) | I.V. | T: Histology I: NRV | Acute | 75% | |
| Johansen et al., | 12 | 8–9 | 15 | F | Yorkshire-Landrace crossbred | 5–15 days | None | 5.50, 500, 5 × 103 or 5 × 104 | 0.5 ml | I.A. | T: Microbiology + Histology I: NRV | Acute | 5 × 103 CFU: 50% 5 × 104 CFU: 100% | |
| Johansen et al., | 11 | 12 | 30 | F | Yorkshire-Landrace crossbred | 11–15 days | None | 104 | 1 ml | I.A. | T: Microbiology + Histology (PNA FISH) I: NRV | Chronic | All strains: 44% S54F9: 100% | |
| Johansen et al., | 5 | 12 | 30 | F | NR | 11–15 days | None | 104 | 1 ml | I.A. | T: Microbiology + Histology I: NRV | NR | 100% | |
| Johansen et al., | 4 | 12 | 30 | M/F | Yorkshire-Landrace crossbred | 6–8 days | None | 5 × 105 and 5 × 106 | 1 ml | I.A. | T: Microbiology + Histology I: NRV | Chronic | 100% | |
The percentage of animals with infection. T, verification method in tissue; I, verification method on implant; CFU, colony forming units; NR, not registered; F, female; M, male; I.V., intravenous; I.A., intraarterial; NRV, not relevant.
Porcine models of implant-associated osteomyelitis.
| Koschmieder et al., | 5 | 12 | NR | NR | Domestic landrace | 16 days | Traumatic Bone cement | 2 × 108 | 2 ml | Traumatic | T: Microbiology I: NR | NR | NR | |
| Patterson et al., | 8 | 104–260 | 68–95 | F | Yucatan mini-pigs | 12 weeks | Traumatic Bone cement or bone wax | 108–109 | 1 ml | Traumatic | T: Microbiology I: NR | Chronic | All strains: 100% | |
| Rink et al., | 10 | NR | 50-65 | M | Yorkshire-Pietrain crossbred | 28 days | 18G needle | 1.2 × 103 | NA | Traumatic | T: Radiography I: NR | NR | NR | |
| Jensen et al., | 42 | 12 and 32 | 30 and 60–67 | F | Danish landrace | 5 days | Kirschner wire | 102–104 | 10 μl | Traumatic | T: Microbiology + Histology I: PNA FISH | Chronic | 33- 83% | |
| Jensen et al., | 12 | NR | 30 | M/F | NR | 2–6 days | Kirschner wire | 104 | 10 μl | Traumatic | T: Microbiology + Histology I: PNA FISH + SEM | Acute + Chronic | 67% | |
| Tøttrup et al., | 10 | NR | 67–77 | F | Danish landrace | 5 days | Kirschner wire | 104 | 10 μl | Traumatic | T: Microbiology + Histology I: NR | Acute | 100% | |
The percentage of animals with infection. T, verification method in tissue; I, verification method on implant; CFU, colony forming units; NR, not registered; F, female; M, male.